Today on DrugResearcher.com
 
New bull's-eye for obesity fighting drugs

Best biopharma bosses

Ventana to help develop pathway for companion diagnostics

It's a NanoDrop for Thermo Fisher Scientific

Drugs moving into the clinic: 31

 
   
Related Industry News
 
Boehringer UK plant 'couldn't compete'

Cough and cold products for under-twos recalled

Patch-based travel vaccine looks good

UCB opens Irish facility

 
 

Drug discovery

Breaking News on Drug Discovery
Daily  Friday 12 October 2007 Forward to a colleague

Sponsored Link

Select & isolate mammalian clones by surface proteClonePix FL - explore cell surfaces discover stellar clones

ClonePix FL technology makes light-work of selecting and isolating mammalian cell clones by cell surface protein expression, rapidly yielding monoclonal populations for cell based assays, screening, downstream phenotyping/genotyping and basic discovery research... Click Here

Access Full Stories



New bull's-eye for obesity fighting drugs
Drug developers have a new target to aim at in the fight against obesity after the discovery that a certain protein in the body stimulates the formation of fat cells... Read


Best biopharma bosses
There have been a few changes in the top ten employers according to leading journal Science's annual survey of the best companies to work for in the biotech, biopharma, pharmaceutical and related industries... Read


Ventana to help develop pathway for companion diagnostics
The Critical Path Institute (C-Path) and diagnostics expert Ventana Medical Systems are collaborating to develop a standard submission route for targeted therapies and companion diagnostics... Read


It's a NanoDrop for Thermo Fisher Scientific
Thermo Fisher Scientific has acquired micro-volume UV-Vis (ultra violet visible) instrument manufacturer NanoDrop Technologies for an undisclosed amount... Read


Drugs moving into the clinic: 31
The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read


All News Headlines for:
October | September | August

ESA BioSciencesTechnical / White Paper

Manufacturing Variations in Polysorbate Batches

Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here

Related Industry News



Boehringer UK plant 'couldn't compete'
Boehringer Ingelheim has been forced to announce the planned closure of a UK manufacturing site as a result of pricing pressures that mean the firm is unable to produce unit dose vials (UDVs) at the site cost-effectively... Read


Cough and cold products for under-twos recalled
Several big drug-makers are voluntarily recalling some of their cough and cold products for under-two-year-olds in the US as a precautionary measure against overdosing on the drugs... Read


Patch-based travel vaccine looks good
The first vaccine for travellers' diarrhoea is looking promising after the announcement of Phase II results... Read


UCB opens Irish facility
UCB is a wee bit excited after the opening of its newly expanded Irish facility, which will manufacture the company's overactive bladder drug, anticipated to be launched within the next two years... Read


Weekly Comment

FDA told its safety monitoring of clinical trials not good enough

The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials. Read



ChromswordProduct Presentation

Rapid HPLC method development with ChromSword®Auto software

Avoid the tedious search for good HPLC methods for separation with ChromSword®Auto's quicker chromatography solutions... Click Here
Previous Headlines



Lab-on-a-chip enables cell-free protein synthesis
Researchers have developed a new microfluidic device that enables high-throughput (HT), cell-free protein synthesis for genomic and proteomic functional analysis... Read


Wyeth and Zealand seek to still irregular beating heart
Wyeth has begun first-in-man trials for an oral drug designed to calm an irregular heart beat, triggering a milestone payment to its partner on the project, Denmark-based Zealand Pharma... Read


GSK, Synta join forces in billion dollar cancer deal
GlaxoSmithKline (GSK) has signed a deal worth around a billion dollars with US biopharma firm Synta, over its first-in-class melanoma drug, a notoriously difficult cancer to treat... Read


Kinaxo adds new proteomics service
Kinaxo Biotechnologies is now offering a new proteomics service to help drug developers decide which drug candidates to move through the preclinical process... Read


Ablynx decides to go it alone with camel-based mini-antibodies
Ablynx, a biopharma firm that specialises the potentially lucrative sector of miniature antibodies, has announced it plans to launch on the stock market this year... Read

Product Information - brochures, Web centers
Separation of polar compounds - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com